 1 Overview Annual Report and Accounts 2009
www.omegadiagnostics.com
Reported revenue up 56% and 20% like-for-like
Sales growth in established and new markets 
Operating profits almost doubled in year
Launch of new colourimetric version of the microarray technology
Launch of macroarray-based Food Detective
™
 kit into multiple territories
Overview 
01 The Highlights of 2009
02 Our Strategy
04 Global Reach
06 Investing in Technology
08 Our Key Products
10 Chairman’s Statement
 
Business Review 
12 Chief Executive’s Review
16 Financial Review
19 Board of Directors
 
Governance 
20 Directors’ Report
22 Directors’ Remuneration Report
24 Corporate Governance Report
26 Statement of Directors’ Responsibilities
 
Audit Report 
27  Independent Auditor’s Report to the 
members of Omega Diagnostics Group PLC
Financial Statements 
28 Consolidated Income Statement
29 Consolidated Balance Sheet
30  Consolidated Statement  
of Changes in Equity
31 Consolidated Cash Flow Statement
32 Company Balance Sheet
33 Company Statement of Changes in Equity 
34 Company Cash Flow Statement
35 Notes to the Financial Statements
60 Notice of Annual General Meeting
IBC Advisers
The Highlights of 2009
Strategy
Our business strategy remains unchanged. Omega aims  
to deliver organic growth from recently acquired products, 
markets and technologies. Omega will also continue  
to pursue acquisition opportunities which are earnings  
enhancing or strategically placed in major growth markets.
Read more on our 
Strategy and Growth
page 2
Growth
